| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.2 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.078 | 0.2 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.066 | 0.2 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.2 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.2 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |